The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisive role in restricting fair access to a life-saving health product. This report focuses on six leading vaccine developers, AstraZeneca, BioNTech, Johnson & Johnson, Moderna, Novavax and Pfizer, assessing each company’s human rights policy, pricing structure, records on intellectual property, knowledge and technology sharing, allocation of available vaccine doses and transparency.
[2]
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/reports-documents/double-dose-inequality-pharma-companies-and-covid-19-vaccines-crisis
[2] http://www.indiaenvironmentportal.org.in/files/file/A double dose of inequality.pdf
[3] http://admin.indiaenvironmentportal.org.in/category/publisher/amnesty-international
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/coronavirus
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/global
